The broad mission of our conferences is to understand and confront the issues surrounding the early diagnosis and early treatment of lung cancer; and to expand the reach of practice-relevant research to medical and scientific communities in the U.S. and abroad.
The Seattle conference will focus on:
- Extending the reach of screening programs
- Treatment of early lung cancer
- Interstitial Lung Disease (ILD)
- Risk assessment
- Screening economics